[-] Show simple item record

dc.contributor.authorDresang, Lee T.eng
dc.date.issued2011-12eng
dc.description.abstractThere are no RCTs or other quality evidence to recommend either intramuscular (IM) or intravenous (IV) oxytocin over the other for management of the third stage of labor. Professional bodies recommend both routes of administration equally.eng
dc.identifier.citationEvidence Based Practice 14(12): 12.eng
dc.identifier.urihttp://hdl.handle.net/10355/12346eng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofEvidence Based Practice 14(12): 12.eng
dc.relation.ispartofcollectionEvidence Based Practice, 2011eng
dc.relation.ispartofseriesTopics in Maternity Care (Evidence Based Practice, 2011)eng
dc.subjectuterotonic agenteng
dc.subject.lcshChildbirtheng
dc.titleIntramuscular vs intravenous oxytocin for active management of the third stage of laboreng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record